FENC Award Disclosure
Sayad Pierre Sargis · SEC Form 4 · Filed Nov 2, 2026
Award
Calculated transaction value
$0
Sayad Pierre Sargis Chief Medical Officer
FENC
Transaction date
Oct 31, 2026
Public filing date
Nov 2, 2026
Filing lag
Filed 2 days later
FENC daily price context
Close on/before transaction
$10.24
Oct 30, 2026
First close after public filing
$10.7
Nov 3, 2026
Return after filing · so far
-8.32%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Shares
- Quantity / price
- 168 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0002043395-26-000018
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Fennec Pharmaceuticals Inc. FENC Current | Award | Oct 31, 2026 | $0 |